Timothy Price, Interim Clinical Trials Chair at SACCaN, Associate Editor of ESMO GI Oncology, Chair of the Australian CRC guidelines, shared a post by George Pentheroudakis, Chief Medical Officer, European Society for Medical Oncology, on LinkedIn, adding:
“As Chair of the Australian CRC guidelines I would suggest this becomes our new reference for rectal cancer while we await funding to allow future updates. Things have changed since 2017/18. It was a privaledge to have been invited to contribute to the ESMO guidelines.”
Quoting George Pentheroudakis‘s post:
“ESMO with a new Rectal Cancer CPG!”
Earlier this week ESMO shared a post on LinkedIn:
“Updated ESMO Clinical Practice Guideline on localised rectal cancer: situation-dependent intensification and de-intensification, complex radiological factors, biomarkers and selective Tx goals via organ-preserving strategies form options and decisions ESMO Guidelines.”
Read Full ESMO Clinical Practice Guideline on ESMO.
More posts featuring ESMO on OncoDaily.